Skip to content

Supplier News

Gorsky elected chairman of Johnson & Johnson

Seven months after becoming chief executive officer, Alex Gorsky has been elected as chairman of the board at Johnson & Johnson. J&J said Friday that current chairman Bill Weldon, Gorsky’s predecessor as CEO, is slated to step down on Dec. 28 and to retire early next year after a brief transitional

Mylan releases generic Detrol

Mylan Inc. has been cleared by the Food and Drug Administration to market tolterodine tartrate tablets (1 mg and 2 mg), a bladder medication. The company said Thursday that the product, which is shipping immediately, is a generic version of Pharmacia and Upjohn’s Detrol tablets.

Coty plans Katy Perry fragrance line

Coty Inc. has signed singing star Katy Perry to develop and market her own line of signature fragrances. The company said Wednesday that as part of the project it will also distribute Perry’s existing fragrance portfolio, comprised of Purr and Meow!, effective immediately.

MigreLief expands distribution to CVS

Akeso Health Sciences is rolling out its MigreLief Triple Therapy with Puracol migraine remedy at CVS/pharmacy stores nationwide and on CVS.com. Akeso said Tuesday that both its MigreLief Original Formula and MigreLief+M menstrual migraine formula hit shelves at CVS stores this week.

Stopain signs ex-NFL quarterback as spokesman

Troy Healthcare has signed former NFL quarterback Ron Jaworski as a national spokesman for its Stopain line of topical analgesics. The company said Monday that Jaworski, who played for the Philadelphia Eagles and now serves as an ESPN football analyst, is a natural ambassador for the Stopain brand.

Ranbaxy recalls generic Lipitor in U.S.

Ranbaxy Pharmaceuticals Inc. is voluntarily recalling select batches and dosages of atorvastatin calcium tablets, a generic version of the cholesterol-lowering drug Lipitor, in the United States. The drugmaker said on its website Friday that the recall is being conducted in the U.S.

Reckitt Benckiser inks deal to acquire Schiff

Reckitt Benckiser Group has signed an agreement to acquire Schiff Nutrition International Inc. in a $1.4 billion deal. The agreement comes less than a week after Reckitt Benckiser announced a tender offer to buy all of the outstanding shares of Schiff for $42 per share in cash.